Lamictal (lamotrigine) Chewable Dispersible Tablets
Company: GlaxoSmithKlineApproval Status: Approved June 1999
Treatment for: Neurology
Areas: Neurology & Nervous System
Possible similar drugs: Lamictal Chewable Dispersible Tablets
General Information
The approval of these efficacy supplements provide for the use of Lamictal as conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug.
Lamictal Drug Information
The Lamictal drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
